Leading the Future of AI-Powered Dementia Detection
Cognes wins Brilliant Minds 2025 for its AI-driven dementia screening tool using facial biomarkers. A milestone for innovation in healthtech and longevity.
A Global Spotlight on AI and Early Dementia Detection
Cognes Medical Solutions, an emerging force in AI-powered healthtech, has been named the Brilliant Minds Innovator of the Year 2025 – a prestigious global award celebrating breakthrough solutions that can shape the future of humanity.
With this honor, Cognes’ mission to transform dementia care through early, accessible, and ethical AI screening tools is now at the center of global attention.
This recognition is not only a celebration of our team’s work, it’s a call to action for investors, researchers, and healthcare leaders who believe in a future where neurodegenerative diseases can be detected earlier and treated more effectively.
A Global Gathering with a Purpose
The 2025 Brilliant Minds event brought together visionaries from across the globe – including leaders in technology, healthcare, culture, finance, and social innovation. United by a shared belief in transformative ideas, participants explored how collaboration, ethics, and human values can shape the future.
This year’s theme, centered around empathy and responsibility, was powerfully captured in a closing message from the Brilliant Minds Foundation:
“In a world where you can be anything, be kind.”
At Cognes, this message resonates deeply. As we continue building AI technology to support those living with or at risk of dementia, we are committed to developing with compassion, equity, and care at the core of our work.
Why Cognes? Why Now?
Dementia remains one of the most underdiagnosed medical conditions globally, with up to 75% of cases going undetected until symptoms are advanced. Our solution addresses this gap with:
-
A facial biomarker-based screening tool using computer vision and machine learning
-
A smartphone-based platform for real-world scalability
-
A dual focus on early risk detection and treatment monitoring for research and clinical use
-
A commitment to GDPR-compliant, ethical AI in healthcare
Judges from Brilliant Minds 2025 were deeply moved by our pitch and its global relevance:
“The hope it could provide to the millions of people globally who are impacted by dementia is undeniable.”
— Brilliant Minds Jury
Sandra Challma presenting at Brilliant Minds 2025, where Cognes was awarded Innovator of the Year.
A Movement, Not Just a Milestone
This award signals much more than validation—it signals momentum.
Cognes now stands among the world’s most promising healthtech innovators. With this momentum, we are actively expanding strategic partnerships across:
-
Pharma and CROs for patient stratification and longitudinal monitoring
-
Research institutions seeking advanced, non-invasive digital biomarkers
-
Healthtech investors ready to back a high-impact, AI-driven solution in a €42B market
If you are looking to support a mission-driven, scalable medtech platform built for real-world impact, now is the time to engage.
Our Vision: Ethical AI in Service of Brain Health
At Cognes, we believe in a world where:
-
Dementia is detected early—before life-altering decline begins
-
Treatments are personalized and monitored with objective data
-
Patients and families have time to act, plan, and hope
Our solution is not a diagnostic tool. It is a screening and monitoring platform – a first step toward timely care, improved trials, and reallocated healthcare resources. Built with transparency and security at its core, Cognes combines facial recognition AI, digital health data, and scientific partnerships to empower both clinicians and patients.
What’s Next?
We are scaling toward:
-
Global validation studies in collaboration with top-tier research sites
-
A commercial launch in the research and pharma sectors by 2026
-
Regulatory pathways in Europe, the US, and Asia for responsible expansion
Now is the time for forward-thinking investors to join us in reshaping the trajectory of cognitive health.
Cognes isn’t just building a product. We are building a future where dementia is no longer invisible.
Join Us
Whether you are an investor, researcher, caregiver, or advocate for brain health, we welcome you to join our mission.
🔗 Contact us for investment or partnership opportunities
🔗 Explore our platform
🔗 Sign up for our quarterly newsletter